Outreach Workers

Tuberculosis (TB), a contagious bacterial infection primarily affecting the lungs, remains a health risk in the U.S. Though cases declined for decades, recent increases — including ~10,347 cases in early data from 2024 — suggest testing and treatment of latent TB is needed more than ever.  Testing is crucial both for diagnosing latent TB (where bacteria are present but symptoms are absent) and active TB disease (which is contagious and manifests symptoms).

Syphilis remains a persistent sexually transmitted infection that requires rigorous diagnosis and management to prevent transmission, progression, and severe complications. This guideline distilled by Praxis Medical Insights outlines the current consensus from the Centers for Disease Control and Prevention (CDC) and related professional bodies on optimal screening methods, diagnostic interpretations, and treatment regimens.

The webpage highlights the disproportionate rates of Hepatitis C virus among American Indian/ Alaska Native communities. This webpage highlights the Cherokee National Health Services acute Hepatitis C virus (HCV) elimination program, which provides community based testing at food distribution centers, universal screening, and rapid point of care diagnostics. Programs such as HCV and Linkage to Program (HELP) use telehealth to connect patients with providers. Project ECHO builds clinical capacity for local practitioners.

This information sheet explains the requirement for insurers to cover Pre-Exposure Prophylaxis (PrEP) without cost-sharing. 

This information sheet provides guidance on covering the costs of PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis). 

This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.

This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.

This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.

This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.

This fact sheet provides guidelines on how to use doxy PEP (doxycycline post-exposure prophylaxis) as a preventive measure against sexually transmitted infections (STIs). It outlines proper dosage, timing, and considerations for individuals at risk of exposure to STIs, offering a key resource for enhancing STI prevention strategies.